Key result
Non-invasive vascular testing accurately detects carotid disease, potentially reducing negative angiograms.
Why the study?
Non-invasive vascular testing is used to identify patients with significant extracranial carotid artery disease and may reduce negative carotid angiograms, but its diagnostic value needed analysis.
Does non-invasive cerebrovascular testing effectively identify significant extracranial carotid artery disease in patients with suspected disease?
Population
157 patients undergoing 159 studies for extracranial carotid artery disease including those with TIAs or soft signs
Comparison
Non-invasive cerebrovascular laboratory testing vs carotid angiography
Design
Observational analysis of diagnostic studies
Authors
Loading...
Noninvasive testing may limit unnecessary angiography in carotid disease; leaves open validation against contemporary imaging in TIA pathways.
Observational (n=157)
Does non-invasive cerebrovascular testing effectively identify significant extracranial carotid artery disease in patients with suspected disease?
Non-invasive cerebrovascular testing is an effective diagnostic tool that can identify significant carotid artery disease and potentially reduce unnecessary angiograms.
Goran et al. (1980) conducted an observational in extracranial carotid artery disease (n=157). Non-invasive vascular testing was evaluated on diagnosis of extracranial carotid artery disease. Non-invasive vascular testing in 157 patients was identified as an effective means of diagnosing significant extracranial carotid artery disease and potentially reducing negative carotid angiograms.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: